Activation of the microglial P2X7R/NLRP3 inflammasome mediates central sensitization in a mouse model of medication overuse headache
BackgroundExcessive use of headache treatments often leads to the development, progression and exacerbation of primary headache, which is defined as medication overuse headache (MOH). A significant pathophysiological mechanism of MOH is central sensitization. Recent evidence suggests that central se...
Main Authors: | Yanyun Wang, Liang Dong, Yun Zhang, Yixin Zhang, Guangcheng Qin, Dunke Zhang, Lixue Chen, Wei He, Jiying Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2023.1177171/full |
Similar Items
-
Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression
by: Qiuqin Han, et al.
Published: (2024-01-01) -
Neuroprotection of Emodin by Inhibition of Microglial NLRP3 Inflammasome-Mediated Pyroptosis
by: Wen Jiang, et al.
Published: (2023-03-01) -
Medication-Overuse Headache: Update on Management
by: Prut Koonalintip, et al.
Published: (2024-09-01) -
A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities
by: Srdjan Ljubisavljevic, et al.
Published: (2023-10-01) -
Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
by: Hans-Christoph Diener, et al.
Published: (2022-08-01)